Oncology Resource Group (ONCrg) is the competitive intelligence vendor of choice in Acute Lymphoblastic Leukemia. Our unmatched expertise is cultivated by continuous study of the area allowing us to deliver cutting-edge reports with unparalleled depth, breadth, and insight.
ONCrg Conference™ delivers unrivaled competitive intelligence from major congresses. ONCrg’s syndicated model covers the entire Acute Lymphoblastic Leukemia landscape, but leaves room to add or drill down on your interests, so highly relevant reports are produced, including our expert opinions about the implications of new data on your pipeline.
Competitive Landscape Analysis
*Under Development. ONCrg Pipeline Strategies™ delivers cutting-edge profiles across the entire Acute Lymphoblastic Leukemia competitive landscape, providing valuable analytics by class and treatment subset for new drugs in Phase I/II development and beyond. Reports are updated quarterly and written in two formats:
- a presentation format for higher level comparative analytics
- a corresponding compendium with additional detailed commentary from ONCrg experts
Monthly Surveillance Reports
*Under Development. ONCrg Sentinel™ provides vigilant monitoring of rapidly evolving scientific, clinical, and commercial activities in Acute Lymphoblastic Leukemia. ONCrg experts identify and analyze events and deliver incisive commentaries to inform subscribers each month and prepare them to respond wisely to changing market conditions.
Expert Advisory Guidance
ONCrg Advisory™ is an open door to ask non-proprietary questions in Acute Lymphoblastic Leukemia and your other subscription areas. Our experts utilize extensive resources and experience to provide extra guidance to inform clients’ key decisions.
*Call for details.